Study is to show that QVA149 is superior to the standard of care, fluticasone/salmeterol, in
patients with moderate to severe airflow limitation.
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Novartis Investigative Site, Buenos Aires 1425, Argentina
Novartis Investigative Site, Buenos Aires C1115AAB, Argentina
Novartis Investigative Site, Buenos Aires C1122AAK, Argentina
Novartis Investigative Site, Buenos Aires, Argentina
Novartis Investigative Site, Mendoza 5500, Argentina
Novartis Investigative Site, Mendoza M5500CBA, Argentina
Novartis Investigative Site, Antwerpen 2060, Belgium
Novartis Investigative Site, Bruxelles 1000, Belgium
Novartis Investigative Site, Genk 3600, Belgium
Novartis Investigative Site, Gilly 6060, Belgium
Novartis Investigative Site, Hasselt 3500, Belgium
Novartis Investigative Site, Jambes 5100, Belgium
Novartis Investigative Site, Barranquilla, Colombia
Novartis Investigative Site, Florida Blanca, Colombia
Novartis Investigative Site, MedellĂn, Colombia
Novartis Investigative Site, Cvikov 471 54, Czech Republic
Novartis Investigative Site, Jindrichuv Hradec 377 01, Czech Republic
Novartis Investigative Site, Karlovy Vary 360 66, Czech Republic
Novartis Investigative Site, Kurim 664 34, Czech Republic
Novartis Investigative Site, Pardubice 530 09, Czech Republic
Novartis Investigative Site, Teplice 415 01, Czech Republic
Novartis Investigative Site, Karamsad 388225, India
Novartis Investigative Site, Guntur, Andhra Pradesh 522 001, India
Novartis Investigative Site, Kyjov, CZE 697 70, Czech Republic
Novartis Investigative Site, Ahmedabad, Gujarat 380 008, India
Novartis Investigative Site, Faridabad, Haryana 121 001, India
Novartis Investigative Site, Bangalore, Karnataka 560 002, India
Novartis Investigative Site, Nagpur, Maharashtra 400 012, India
Novartis Investigative Site, Pune, Maharashtra 411004, India
Novartis Investigative Site, Jaipur, Rajasthan 302004, India
Novartis Investigative Site, San Miguel de Tucuman, Tucuman 4000, Argentina